VigiLanz Ranked No. 1 by KLAS Research for Pharmacy Surveillance for Sixth Consecutive Year

Posted on February 8, 2023February 8, 2023 by Leo Bogee

The patient safety company most trusted by hospitals is recognized as Best in KLAS, totaling 12 KLAS awards in 6 years

MINNEAPOLIS, FEBRUARY 8, 2023 — VigiLanz, a patient safety company, today announced that it has earned the 2023 Best in KLAS designation from KLAS Research for Pharmacy Surveillance.

This is the sixth consecutive year that VigiLanz has been recognized by KLAS as the industry leader in Pharmacy Surveillance, bringing its total count of KLAS awards to 12. These awards span various categories and include Antimicrobial Stewardship, which was folded into the Pharmacy Surveillance award in 2021.

The VigiLanz clinical surveillance platform, which houses the award-winning Pharmacy Surveillance solution, helps clinicians deliver safer, higher quality patient care by converting disparate EHR data into uniform, actionable intelligence.

VigiLanz Pharmacy Surveillance continuously monitors data from the EHR and ancillary clinical systems to improve medication safety, standardize practices, and maximize efficiencies. Based on the system’s built-in rule sets or hospital-specific guidelines, it automatically generates warnings and alerts that help clinicians make appropriate drug therapy decisions.

“VigiLanz Pharmacy Surveillance has been phenomenal. We are able to do a lot more with VigiLanz Pharmacy Surveillance than we could with just the EHR. The solution is easy for the end users. It requires almost no training at all.”

– Manager, June 2022, klasresearch.com

In addition to Pharmacy Surveillance, VigiLanz offers a variety of solutions, including Infection Prevention, Antimicrobial Stewardship, Safety Surveillance, Risk and Claims, Audit, Clinical and Quality Services, and Research. These solutions create an umbrella of protection for hospitals and their patients, facilitating a system-wide approach that provides a crucial and additional layer of safety protection while reducing risks, enhancing patient and staff satisfaction, and streamlining workflows.

“We are extremely proud to receive national recognition from KLAS for the sixth consecutive year,” said VigiLanz Chairman and CEO David Goldsteen, MD. “Our solutions work alongside the EHR to bring hospitals to an even higher level of patient safety, helping to identify and prevent patient safety problems in real-time. We’re deeply grateful for the opportunity to help hospitals create safer systems for their patients, and we’re honored to once again receive overwhelmingly positive reactions regarding our solutions.”

“Best in KLAS” is a recognition given to software and services companies who excel in helping healthcare professionals improve patient care. Rankings are based on thousands of customer surveys from healthcare leaders, administrators, clinicians, and others who interact with the solutions.

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers and payers to be heard and counted. Working with thousands of healthcare professionals, KLAS gathers insights on software, services and medical equipment to deliver timely reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly represents the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit www.KLASresearch.com.

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based patient safety solutions. The firm is focused on advancing the delivery of quality care by transforming complex patient data into meaningful and actionable alerts in real-time, helping clinicians identify opportunities to reduce risks and improve safety. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, researchers, and other clinicians dedicated to innovative, real-time inpatient care.

###

For More Information

John Gonda
(616)-309-4888
jgonda@sage-growth.com

Q&A: Sharp HealthCare’s Commitment to, and Experience With, Clinical Trials

Posted on January 11, 2023January 13, 2023 by Leo Bogee

Five questions for DeAnn Cary, PhD, Director of Research at Sharp HealthCare

Clinical trials are critical to advancing medicine and patient health but participating in them is not easy. Hospitals that serve as clinical trial sites must invest significant time and resources into the process, and one of the most time-consuming elements relates to identifying and enrolling patients in clinical trials.

While many hospitals rely on manual reviews, outdated reports, and other time-consuming methods to find the right candidates, innovative clinical trial sites are turning to new technology that makes the identification and enrollment process much more efficient.

One such organization is Sharp HealthCare, which is using VigiLanz Research to accurately and quickly identify eligible candidates for clinical trial enrollment. In this Q&A, DeAnn Cary, PhD, Director of Research at Sharp HealthCare, discusses the hospital’s approach to clinical trials and why it began using this new technology to support its research efforts.

Tell us about Sharp HealthCare and why it participates in clinical trials?

DC: Sharp HealthCare is a not-for-profit health system based in San Diego that is made up of four acute-care hospitals, three specialty hospitals, three affiliated medical groups, and a full spectrum of other facilities and services.

As a community health system, we firmly believe that it is important to offer cutting edge treatments to our patients. Clinical trials provide opportunities to access the newest treatments (e.g., drugs, devices, or procedures) that would not otherwise be available to them.

How do you choose which clinical trials to participate in and how has your overall participation in trials changed over the past few years?

DC: When reviewing new trials, we consider several things including our existing portfolio (we typically avoid having competing trials). We also consider whether our patient population is a good fit, as well as whether we have the resources and bandwidth required to meet the requirements and timelines.

We have increased our participation and patient volume in some areas, such as Alzheimer’s. We have decreased our patient volume in other therapeutic areas, such as oncology. Study design and precision medicine has dramatically expanded the inclusion/exclusion criteria making it much harder to find patients who qualify. Precision medicine is definitely better for the patients but more challenging for the teams trying to recruit.

What methods have you historically used to recruit patients?

DC: We advertise for some studies, particularly for those which the sponsor pays for all activities associated with the study. In other therapeutic areas, in which insurance is involved (such as oncology), it’s more challenging to advertise because not all potential patients have insurance that the clinics accept. In those instances, the recruitment process is highly manual and primarily consists of chart reviews.

How have you improved your clinical trial processes over the years?

DC: The biggest significant improvement in processes has been the use of VigiLanz Research. VigiLanz Research leverages study-specific inclusion and exclusion criteria to automatically review all patients across a hospital network. It screens the entire patient population to identify eligible patients in real time and provides automated alerts and notifications to key team members when there are eligibility matches.

Key benefits of VigiLanz Research include the real-time patient identification for studies that have a very short timeline for identification and recruitment (e.g., cardiac and stroke).

VigiLanz Research has also enabled our small staff of clinical research coordinators to feel confident that they have not missed a single qualified potential research participant. It has also enabled them to focus their time and energies on the patients who meet or nearly meet the study criteria, rather than having to manually review hundreds of patient charts.

“VigiLanz Research has also enabled our small staff of clinical research coordinators to feel confident that they have not missed a single qualified potential research participant.”
—DeAnn Cary, PhD, Director of Research at Sharp HealthCare

Do you believe VigiLanz Research will make Sharp a better candidate for future clinical trials?

DC: Yes, and we are starting to see some of our sponsor feasibility questionnaires ask if we are using a real-time patient identification platform. As this becomes more common, having a technology like VigiLanz Research will continue to be critical, not only for our success within particular trials, but in our ability to continue participating in trials in general.

Read this case study to learn more about how Sharp is using VigiLanz Research to support clinical trial enrollment.

Related Resources: VigiLanz Research

How One Hospital Successfully Transitioned to a New Patient Safety Reporting System

Posted on July 25, 2022July 25, 2022 by Leo Bogee

Learn how Community Health Network, a multi-hospital system serving Central Indiana, underwent a successful transition in patient safety event reporting software in the midst of the pandemic.

Presented in May 2022 by VigiLanz and M. Danielle Dillon, MHL, BSN, RN, CCRN-K, Network Blood Management Director at CHN.

Key webinar learning points:

The criteria used to evaluate vendors based on identified problems
Lessons and tips for successful implementation, training, and launch processes
How the new reporting system positively impacted many areas of the hospital

Transforming hospital safety: How the pandemic is serving as a catalyst for change

Posted on April 1, 2022April 5, 2022 by Leo Bogee

Held at the two-year anniversary of the World Health Organization’s declaration of the COVID-19 pandemic, this webinar panel of hospital leaders discussed the challenges they’ve faced in the last two years — as well as the steps they are taking to improve the future of hospital safety for patients, staff and visitors.

The panel of infection preventionists, pharmacists and hospital executives also shared insights from the fourth annual Hospital Patient Safety Report. Based on a January 2022 survey of 100 hospital leaders, the report reveals hospitals’ biggest safety challenges and priorities.

Key webinar learning points:

Safety challenges exposed by the pandemic
Safety improvements made at the outset of the pandemic that had a long-term impact
Leading hospitals’ planned safety improvements and priorities for 2022
How hospitals are preparing for future pandemic-like situations

A New Vision For Hospital Safety

Posted on March 30, 2022May 25, 2022 by Leo Bogee

The Steps Leading Hospitals Are Taking To Overcome The Safety Challenges

What safety challenges are on hospitals’ watch lists, and what are they doing to overcome them? This infographic—featuring insights gathered from VigiLanz’s Hospital Patient Safety Report 2022, Becker’s Hospital Review, JAMA, and more—has answers.

Download the infographic

VigiLanz Ranked No. 1 by KLAS Research for Pharmacy Surveillance for Fifth Consecutive Year

Posted on February 8, 2022February 8, 2023 by Leo Bogee

The clinical surveillance company most trusted by hospitals is recognized as Best in KLAS, totaling 11 KLAS awards over 5 consecutive years

MINNEAPOLIS, FEBRUARY 8, 2022 — VigiLanz, a clinical surveillance company, today announced that it has earned the 2022 Best in KLAS designation from KLAS Research for Pharmacy Surveillance.

This is the fifth year that VigiLanz has been recognized by KLAS as a leader, bringing its total count of KLAS awards to 11. These awards span various categories, including Infection Control and Monitoring and Antimicrobial Stewardship, the latter of which KLAS folded into Pharmacy Surveillance last year.

The VigiLanz clinical surveillance platform, which houses VigiLanz’s Pharmacy Surveillance solution, converts disparate EHR data into uniform, actionable intelligence that helps clinicians make smarter business decisions while delivering the highest quality patient care. Earning a score of 92.6, VigiLanz Pharmacy Surveillance continuously monitors data from the EHR and ancillary clinical systems to maximize efficiencies, standardize practices, and improve medication safety. Based on the system’s built-in rule sets or hospital-specific guidelines, it automatically generates warnings and alerts that help clinicians make appropriate drug therapy decisions.

“I am very happy with VigiLanz Pharmacy Surveillance. We will definitely keep using it. It is easy to use, and it has made a world of difference. This is the first time we have had a product like this. VigiLanz Pharmacy Surveillance replaced the manual process that we were using through our EHR.”

- Manager, October 2021, klasresearch.com

In addition to pharmacy surveillance, VigiLanz offers a variety of solutions on its clinical surveillance platform, including Infection Prevention, Antimicrobial Stewardship, Safety Surveillance, Risk and Claims, Audit, Clinical and Quality Services, and Corporate Services. These solutions create an umbrella of protection for hospitals and their patients, facilitating a system-wide approach that reduces risks, improves safety, enhances patient and staff satisfaction, and streamlines workflows.

“As our hospital customers continue to face enormous challenges as a result of the ongoing COVID-19 pandemic, we are extremely proud to once again receive national recognition from KLAS for the fifth consecutive year,” said VigiLanz Chairman and CEO David Goldsteen, MD. “Our customers continue to rely on us during the most critical times — from triaging COVID-19 cases, to monitoring the use of life-saving pharmaceuticals during a shortage, or saving clinicians valuable time by providing real-time alerts and reports so they can focus more on caring for their patients. It’s our job to help hospitals keep patients safe, and we’re honored to once again see overwhelmingly positive reactions regarding the platforms, products and solutions that we offer.”

Best in KLAS is a recognition given to vendors for outstanding efforts to help healthcare professionals deliver better patient care. The Best in KLAS designation is reserved for the software and services market segments that have the broadest operational and clinical impact on healthcare organizations. Rankings are based on customer surveys of North American healthcare leaders, administrators, clinicians, and others who interact with the solutions.

About KLAS

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient care.

###

For More Information

John Gonda
(616)-309-4888
jgonda@sage-growth.com

Community Health Network Uses VigiLanz to Improve Safety Event Reporting

Posted on October 21, 2021January 24, 2023 by Leo Bogee

Customer Profile

Community Health Network (CHN), a large health system based in Indianapolis, Indiana, serves more than 618,000 patients across nine hospitals and more than 200 sites of care. With nearly 60,000 inpatient admissions annually and more than 280,000 emergency room visits, CHN is known for its commitment to ensuring optimal safety for patients, staff, and visitors.

Challenge

Most hospitals use basic safety event reporting mechanisms to monitor safety events and identify improvement opportunities. But the effectiveness of these mechanisms is often limited by cumbersome documentation workflows and poor investigative and analytics tools. This reduces the likelihood that safety events will be reported and that safety gaps and trends will be identified and addressed.

CHN knew there had to be a better way, so in 2018, the health system began searching for a new solution that could replace its current vendor and provide more value across the enterprise. “The goal was to provide staff with efficient and intuitive event reporting workflows, while also implementing new investigative and analytics tools,” said Danielle Dillon, MHL, BSN, RN, CCRN-K, who serves as Blood Management Director for the entire CHN health system and who previously served as Risk Manager for Community Hospital East, a CHN hospital in Indianapolis. “We work hard to instill a culture of continual safety improvements, so we’re always looking for new approaches to be even more successful.”

Solution

Community Health Network evaluated several different event reporting solutions before selecting VigiLanz, an award-winning event reporting and clinical surveillance platform that optimizes reporting through real-time alerts, auto-detection of events, management and investigation tools, and analytics and reporting capabilities.

“We felt confident that VigiLanz would meet our current event reporting needs, but also work with us to help address any future objectives,” said Dillon, noting that the solution also stood out due to its form customization abilities, efficient documentation processes, ability to provide enterprise-wide and location-specific reports, and cost-effectiveness. “We knew they would help operationalize best practices in reporting, data collection, and collaboration across multidisciplinary teams.”

To ensure a thorough planning and implementation process, CHN formed a team of risk management, patient experience, claims, peer review, and IT leadership. This group worked closely with VigiLanz to ensure the solution would support enhanced collaboration across the enterprise. “Stronger safety event management and reporting workflows would benefit all of these departments, so their involvement was critical,” explained Dillon.

The new safety event management and reporting system, which went live at CHN in November of 2020 and is known as PACER (Patient and Caregiver Event Reporting), spans the breadth of reporting needs, including:

Employee injuries
Security events
Patient complaints and grievances
Safety events and harm events

CHN is also using other solutions in the VigiLanz event reporting suite, including VigiLanz Risk and Claims and VigiLanz Patient Relations, both of which integrate with the safety event platform. Risk and Claims is used to manage and document medical malpractice claims and legal filings and to maintain relevant financial data. Patient Relations is used to streamline the documentation and management of patient and visitor feedback and to identify opportunities for improving patient satisfaction and service recovery.

“There’s potential for one event to touch all of these areas pretty frequently,” said Dillon. “The new approach makes it easy to share information between departments and improves communication.”

“We’re confident that we aren’t missing things and that we’re addressing more potential safety problems and gaps than before.”– Danielle Dillon, MHL, BSN, RN, CCRN-K, Blood Management Director, CHN

Outcomes

According to Dillon, most hospitals and health systems that implement a new event reporting mechanism experience a temporary decrease in reported events, as it can take time for staff members to adjust. That’s not been the case at CHN. “Throughout the implementation processes, our average number of events reported remained stable and is now increasing,” said Dillon. “In 2021, our monthly average number of reported events is 16% higher than it was before we transitioned to the new system.”

She attributes that increase in reported events to more intuitive and efficient workflows for staff members. “We’re confident that we aren’t missing things and that we’re addressing more potential safety problems and gaps than before.”

Key benefits of the new system include the ability to:

Quickly document events through customizable forms, single sign-ons, mobile access, and mandatory fields
Obtain meaningful safety event insights within specific locations and across the enterprise through analytics and investigative tools
Use customizable and automated email notifications and automated escalations to ensure events are properly reviewed and addressed
Train new users with on-demand sessions and frequent live sessions with Q&As

“My job lives and breathes in PACER,” said Dillon. “I can easily access the system and daily report every morning via my cellphone, and I triage things then and there. We’re responding more quickly and it’s easier to track and trend events across every site.”

The new solution is also increasing collaboration across multiple multidisciplinary teams, said Dillon. For example:

The claims department uses the claims tracking system within the event reporting system to manage and document medical malpractice claims and legal filings.
The quality department uses the peer review tool to identify issues that may require quality review of care provided by physicians and/or advanced practitioners.
The patient experience department uses the system to document patient feedback and maintain regulatory compliance.
The risk management department uses the system to coordinate appropriate involvement of expert individuals to identify, assess, track, and trend issues impacting caregiver and patient safety.

“Creating a safer healthcare system is one of the most critical objectives for our industry right now,” said Dillon. “It’s something we strive to do every day at Community Health Network, and our new event management and reporting system is helping us meet that goal.”

To learn more about how VigiLanz helps hospitals improve their patient safety and clinical surveillance, visit https://vigilanzcorp.com/ today.

VigiLanz Announces L. Hayley Burgess, Pharm.D, MBA, BCPP, CPPS as New Chief Clinical Officer

Posted on August 9, 2021August 6, 2021 by Leo Bogee

Proven industry leader brings substantial clinical expertise and patient safety insights to further support company growth and innovation, while exceeding hospital client expectations

MINNEAPOLIS, August 9, 2021 — VigiLanz, a life-saving clinical surveillance company, today announced that Dr. L. Hayley Burgess has been named as the organization’s new Chief Clinical Officer. In this role, Dr. Burgess will provide leadership oversight and strategic vision for the VigiLanz clinical teams, as well as lead regulatory affairs activities, and support clinical innovations and product development.

Dr. Burgess has more than two decades of pharmacy services, patient safety, and medication management system experience and has spearheaded successful initiatives to enhance medication safety and risk mitigation, most recently served as AVP, Pharmacy Services for HCA Healthcare. In this role, she developed the pharmacy services and medication management strategy and vision for 185 hospital and 120 ambulatory surgery center programs.

While at HCA, her accomplishments included leading the antimicrobial management program (achieving a yearly fifty percent antimicrobial drug spend reduction over baseline), leading the clinical pharmacist workflow program that reduced coded adverse drug events by sixty percent, and improving financial resiliency related to high-cost medications (resulting in millions of dollars in drug spend waste). Her team recently won the Institute for Safe Medication Practices (ISMP) Cheers Award for the Clinical Pharmacist Workflow Model.

Previously she served as Director of Performance Improvement at TMIT, a medical research organization, and as a Supervisor of Clinical Pharmacy Specialties at Kaiser Permanente Colorado Division.

“We are excited to have a clinician as experienced and talented as Hayley join our leadership team. Her recent leadership role at one of the nation’s largest healthcare providers—and her many accomplishments in pharmacy and care delivery system leadership—speaks to her ability to augment with unparalleled knowledge, innovation and strategy,” said David Goldsteen, Chairman and CEO. “She has a broad, real-world vision and extensive knowledge that will greatly contribute to our team as we continue to push the boundaries to improve patient outcomes, clinical efficiency and operational efficiency.”

Dr. Burgess serves as a charter member of the Tennessee Hospital Association’s Medication Use and Safety Innovations Committee and Adverse Drug Event Prevention taskforce, in addition to a charter member of the Board of Pharmacy Specialties Employer committee. She is also part of the CDC and Harvard Pilgrim research team leading the INSPIRE trial for smart antimicrobial decision prompts for prescribers.

Dr. Burgess earned her Doctor of Pharmacy degree from Samford University and her Healthcare MBA from Western Governors University. She completed a post-doctoral residency and clinical science research fellowship in Neurobiology and Psychiatric Pharmacology/Pharmacoeconomics at the University of Texas Health Science Center in San Antonio. She is a Board-Certified Psychiatric Pharmacist (BCPP) and is a Certified Professional in Patient Safety (CPPS). Dr. Burgess is also an affiliate faculty member at Lipscomb University, the University of Tennessee, and Belmont University’s College of Pharmacy.

“I am honored to join the exceptional VigiLanz leadership team and further the mission of providing innovative clinical surveillance services to the healthcare industry,” said Dr. Burgess. “The dynamic software solutions we provide save lives, mitigate harm, and positively impact clinical services in hospitals and clinics with an intuitive workflow design. I am committed to our future success and the leadership role our organization’s technology solutions play in redefining clinical workflows, providing exceptional services and designing the future of patient safety event surveillance. VigiLanz’ ability to design meaningful clinical and safety measures, trends, and dashboards for healthcare system consumption is revolutionary!”

About VigiLanz

###

For More Information

John Gonda
(616)-309-4888
jgonda@sage-growth.com

Safety Event Detection and Management: 3 Things Every Hospital Needs

Posted on August 6, 2021December 28, 2022 by Leo Bogee

Lack of automated event detection
Cumbersome documentation workflows
Limited reporting and analytics capabilities

When safety event reporting solutions lack these three features, events are less likely to be reported in a timely manner. Worse, many safety events may be missed altogether. That means hospitals are more likely to experience the same safety problems in the future.

Here’s more on how your hospital can overcome the three key barriers outlined above.

Barrier #1: Lack of automated event detection

Why it’s a problem: In most hospitals, the only method to capture and report safety events is through staff member reporting. This single-method approach often results in delayed reporting and failure to report events at all. For example, staff may not have time to report events, forget to report them, or choose not to report them due to fear of punitive action.

How to overcome it: Automated event detection

What it is: Automated event detection, also known as electronic case finding, is the process of identifying safety events that have occurred using software algorithms and/or rules engines. This process, which can be used in combination with staff reporting, ensures more safety events are captured more quickly.

Automated event detection requires near-real time standardized and normalized data. Cases are found using numerous types of data feeds including, but not limited to, the EMR, nursing notes, imaging, diagnosis and problem lists, medication administrations, and more.

The best event auto-detection solutions capture all types of safety events, including those that affect patients, employees, and visitors.

Automated Event Detection In Action: Narcan Example

VigiLanz Safety Surveillance uses several criteria to automatically detect safety events. For example, if the following criteria are met for the use of Narcan, a safety event is documented:

The administration of Narcan in a patient who has recently received morphine.
The patient has evidence of respiratory depression via a decrease in respiratory rate or oxygen saturation.
The patient is not currently located in a procedure area where the use of Narcan is more routine.

Barrier #2: Cumbersome documentation workflows

Why it’s a problem: Event reporting should not be difficult for your staff members. The harder it is for them to document events, the more likely it is that they will document them incorrectly or won’t document them at all. Cumbersome workflows also increase the likelihood that the reporting will lack the thoroughness necessary to support investigative processes.

How to overcome it: Event form auto-population

What it is: The same data feeds used to automatically detect safety events can also help streamline documentation workflows for staff members. When real-time standardized and normalized data is pulled from these data feeds, that data can be populated into event reporting forms automatically. This significantly reduces staff time spent filling out event forms.

This real-time data can provide additional benefits, including enhanced reporting accuracy and more efficient communication regarding safety events. For example, if certain thresholds are met, the solution can automatically trigger real-time alerts to relevant staff members.

“Identifying patient safety opportunities is a fundamental first step to preventing harm and improving patient care, which is why hospitals promote safety event reporting.”

– James Hoffman, PharmD, Chief Patient Safety Officer, St. Jude Children’s Research Hospital

Barrier #3: Limited reporting and analytics capabilities

Why it’s a problem: In order to foster continual safety improvements, the safety event reporting mechanism must make it easy for healthcare leaders to investigate and act on documented information via reporting and analytics tools. Unfortunately, this is another area in which many safety event reporting mechanisms fall short.

How to overcome it: Automated event detection + form auto-population + reporting tools

What it is: As previously noted, automated event detection and form auto-population are critical to ensuring safety events are identified quickly and documented properly. However, these capabilities are also key to enabling the quick and thorough analysis and investigation of safety events.

Without automated event detection and auto-population, even the best safety event reporting and analytics platforms stumble. Since organizations without automated detection and auto-population tend to capture fewer events and fewer details related to events, their reporting and analytics platforms are working with incomplete data. That means these organizations are missing key safety trends and improvement opportunities.

When automated event detection is used in tandem with a robust set of reporting and analytics tools—such as timelines, cause mapping, solution maps, and fishbone diagrams—hospitals can identify more safety events and safety trends more quickly. This helps them intervene faster to prevent future problems.

“Hospitals increasingly recognize that they must find ways to intervene more quickly when safety events occur. The longer the delay in intervention, the more likely it is a similar event will occur again. Automated event detection and alerts keep patients safer because hospitals can intervene faster.”

– Karen Biesack, Senior Quality and Safety Specialist, VigiLanz

VigiLanz Dynamic Safety Surveillance is a modern, configurable platform for identifying, reporting, managing, and communicating safety events. By incorporating the above capabilities, VigiLanz enables organizations promote a culture of safety while reducing adverse events. Learn more at vigilanzcorp.com/safety-surveillance.

VigiLanz Launches Intelligent Audit Solution for Hospitals, Streamlining and Automating Processes and Expanding #1 Rated Clinical Surveillance Platform

Posted on June 28, 2021June 29, 2021 by Leo Bogee

Configurable forms, automated workflows, and real-time reports help hospitals and health systems strengthen quality oversight and scale quality improvement initiatives

MINNEAPOLIS, June 29, 2021 — VigiLanz, a clinical surveillance company, today announced the launch of a new audit solution built on VigiLanz’s award-winning enterprise software platform. The new solution, VigiLanz Audit, complements VigiLanz’s existing safety, quality, and risk products by streamlining, automating, and optimizing audit processes. In addition to saving time and resources, VigiLanz Audit helps hospitals quickly identify emerging risks and ensure continuous quality improvements.

Recently recognized as Best in KLAS for Infection Control and Monitoring and Pharmacy Surveillance for the fourth consecutive year, VigiLanz applied its more than 20 years of complex, clinical data experience to create VigiLanz Audit.

The solution streamlines the full audit lifecycle, including case identification, data collection and analysis, and decision-making. It helps create and maintain an efficient, repeatable audit process, so hospitals can effectively evaluate improvement initiatives and scale programs when appropriate.

“VigiLanz Audit helps address significant challenges hospitals face related to time-consuming, inconsistent, and resource-burdensome audits,” said Stacy Pur, VigiLanz’s VP of Product Development, noting that many hospitals still rely on paper- and excel-based audit workflows.

VigiLanz Audit helps hospitals complete audits more efficiently and accurately, and as a result, they have more bandwidth to expand their audit and quality improvement programs.

“Previously, hospitals were only able to make improvements as fast as their manual processes and limited staffing resources would allow. Our new solution is a game-changer for patient safety and patient quality. It leads to a cycle of continuous improvement,” said Pur.

VigiLanz Audit supports every type of quality assurance (QA) and quality improvement (QI) healthcare audit, including clinical, environmental, billing compliance, and accreditation readiness. Key features include:

A comprehensive library of ready-to-go and configurable audit forms
Automated identification of eligible cases and automated case reminders
Accurate and repeatable processes
One-click population queries to determine appropriate sample size
Auto-populated forms and conditional form fields
Seamless data integration
Real-time audit reports and dashboards for enterprise-wide visibility

The launch of VigiLanz Audit follows the release of three other VigiLanz solutions: VigiLanz Risk and Claims, VigiLanz Compliance, and VigiLanz Patient Relations. Learn more about these solutions, and VigiLanz Audit, at VigiLanzcorp.com.

VigiLanz earned Best in KLAS in the “2021 Best in KLAS: Software and Services” report, released February 2, 2021. Over the past four years, VigiLanz has earned 10 KLAS awards for its solutions.

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.

Media Contact
John Gonda
(616)-309-4888
jgonda@sage-growth.com